{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:00:31Z","timestamp":1776056431749,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00784-015-1706-y","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:15:04Z","timestamp":1453421704000},"page":"2023-2035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts"],"prefix":"10.1007","volume":"20","author":[{"given":"S.","family":"Zafar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. E.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Cullinan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. K.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"key":"1706_CR1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613\u2013620","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1706_CR2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00784-011-0614-z","volume":"16","author":"JY Ohe","year":"2012","unstructured":"Ohe JY, Kwon YD, Lee H (2012) Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. Clin Oral Investig 16(4):1153\u20131159","journal-title":"Clin Oral Investig"},{"issue":"1","key":"1706_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","volume":"81","author":"Y Takai","year":"2001","unstructured":"Takai Y, Sasaki T, Matozaki T (2001) Small GTP-binding proteins. Physiol Rev 81(1):153\u2013208","journal-title":"Physiol Rev"},{"key":"1706_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","volume":"63","author":"SJ McTaggart","year":"2006","unstructured":"McTaggart SJ (2006) Isoprenylated proteins. Cell Mol Life Sci 63:255\u2013267","journal-title":"Cell Mol Life Sci"},{"key":"1706_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1348-8643(12)00045-6","volume":"10","author":"T Ikebe","year":"2013","unstructured":"Ikebe T (2013) Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw. Oral Sci Int 10:1\u20138","journal-title":"Oral Sci Int"},{"key":"1706_CR6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"302","author":"J Wood","year":"2002","unstructured":"Wood J, Bonjean K, Ruetz S, Bellahcene A, Devy L, Jm F, Castronovo V, Green JR (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302:1055\u20131061","journal-title":"J Pharmacol Exp Ther"},{"key":"1706_CR7","first-page":"667","volume":"144","author":"S Ma","year":"2008","unstructured":"Ma S, Chaisuparat R, Kj C, Meiller TF (2008) Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol 144:667\u2013676","journal-title":"Br J Haematol"},{"issue":"3","key":"1706_CR8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00784-013-1060-x","volume":"18","author":"AM Pabst","year":"2014","unstructured":"Pabst AM, Ziebart T, Ackermann M, Konerding MA, Walter C (2014) Bisphosphonates\u2019 antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay. Clin Oral Investig 18(3):1015\u20131022","journal-title":"Clin Oral Investig"},{"key":"1706_CR9","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","volume":"65","author":"EP Wang","year":"2007","unstructured":"Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ (2007) Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65:1328\u20131331","journal-title":"J Oral Maxillofac Surg"},{"key":"1706_CR10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1073\/pnas.0708474105","volume":"105","author":"C Wan","year":"2008","unstructured":"Wan C, Gilbert SR, Wang Y et al (2008) Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 105:686\u2013691","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1706_CR11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.coms.2007.07.003","volume":"19","author":"Y Sawatari","year":"2007","unstructured":"Sawatari Y, Marx RE (2007) Bisphosphonates and bisphosphonate-induced osteonecrosis. Oral Maxillofac Surg Clin N Am 19:487\u2013498","journal-title":"Oral Maxillofac Surg Clin N Am"},{"key":"1706_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.coms.2007.01.005","volume":"19","author":"AN Chaudhry","year":"2007","unstructured":"Chaudhry AN, Ruggiero SL (2007) Osteonecrosis and bisphosphonates in oral and maxillofacial surgery. Oral Maxillofac Surg Clin N Am 19:199\u2013206","journal-title":"Oral Maxillofac Surg Clin N Am"},{"key":"1706_CR13","doi-asserted-by":"crossref","first-page":"s131","DOI":"10.2215\/CJN.04151206","volume":"3","author":"B Clarke","year":"2008","unstructured":"Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3:s131\u2013s139","journal-title":"Clin J Am Soc Nephrol"},{"key":"1706_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S8756-3282(01)00655-X","volume":"30","author":"ER Beek van","year":"2002","unstructured":"van Beek ER, Lowick CWGM, Papapulos SE (2002) Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates or osteoclast precursors. Bone 30:64\u201370","journal-title":"Bone"},{"key":"1706_CR15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1601-0825.2007.01402.x","volume":"14","author":"D Stefanik","year":"2008","unstructured":"Stefanik D, Sarin J, Lam T, Levin L, Leboy PS, Akintoye SO (2008) Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate. Oral Dis 14:465\u2013471","journal-title":"Oral Dis"},{"issue":"6","key":"1706_CR16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00784-014-1353-8","volume":"19","author":"JT Lee","year":"2015","unstructured":"Lee JT, Choi SY, Kim HL, Kim JY, Lee HJ, Kwon TG (2015) Comparison of gene expression between mandibular and iliac bone-derived cells. Clin Oral Investig 19(6):1223\u20131233","journal-title":"Clin Oral Investig"},{"key":"1706_CR17","doi-asserted-by":"crossref","unstructured":"Dillon JP, Waring-Green VJ, Taylor AM et al (2012) Bone research protocols. Primary human osteoblast cultures. Methods Mol Biol 816:3\u201318","DOI":"10.1007\/978-1-61779-415-5_1"},{"key":"1706_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","volume":"14","author":"C Walter","year":"2010","unstructured":"Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig 14:35\u201341","journal-title":"Clin Oral Investig"},{"key":"1706_CR19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.archoralbio.2010.11.003","volume":"56","author":"MJ Ravosa","year":"2011","unstructured":"Ravosa MJ, Ning J, Liu Y, Stack MS (2011) Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts. Arch Oral Biol 56:491\u2013498","journal-title":"Arch Oral Biol"},{"key":"1706_CR20","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.joms.2011.03.005","volume":"69","author":"M Cozin","year":"2011","unstructured":"Cozin M, Pinker BM, Solemani K, Zuniga JM, Dadaian SC, Cremers S, Landesberg R, Raghavan S (2011) Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg 69:2564\u20132578","journal-title":"J Oral Maxillofac Surg"},{"key":"1706_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.oraloncology.2010.12.003","volume":"47","author":"T Ziebart","year":"2011","unstructured":"Ziebart T, Koch F, Klein MO, Guth J, Adler J, Pabst A, Al-Nawas B, Walter C (2011) Geranylgeraniol\u2014a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw. Oral Oncol 47:195\u2013201","journal-title":"Oral Oncol"},{"key":"1706_CR22","unstructured":"Ohlrich EJ (2010) Bisphosphonates and osteonecrosis of the jaws: angiogenesis-related gene expression in cultured human gingival fibroblasts. DClinDent Thesis, University of Otago."},{"key":"1706_CR23","unstructured":"Zafar s (2014) Effects of Bisphosphonate on cells extracted from oral tissues. PhD Thesis, University of Otago."},{"issue":"9","key":"1706_CR24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/jop.12181","volume":"43","author":"S Zafar","year":"2014","unstructured":"Zafar S, Coates DE, Cullinan MP, Drummond BK, Milne T, Seymour GJ (2014) Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts. J Oral Pathol Med 43(9):711\u2013721","journal-title":"J Oral Pathol Med"},{"key":"1706_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.critrevonc.2008.07.008","volume":"69","author":"D Santini","year":"2009","unstructured":"Santini D, Fratto ME, Galluzzo S, Vincenzi B, Tonini G (2009) Are bisphosphonates the suitable anticancer drugs for the elderly? Crit Rev Oncol Hematol 69:83\u201394","journal-title":"Crit Rev Oncol Hematol"},{"key":"1706_CR26","first-page":"e1","volume":"108","author":"A Siddiqi","year":"2009","unstructured":"Siddiqi A, Payne AGT, Zafar S (2009) Bisphosphonates induced osteonecrosis of the jaw: a medical enigma? OOOOE 108:e1\u2013e8","journal-title":"OOOOE"},{"key":"1706_CR27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1096\/fasebj.8.11.7520879","volume":"8","author":"EJ Kovacs","year":"1994","unstructured":"Kovacs EJ, DiPietro LA (1994) Fibrogenic cytokines and connective tissue production. FASEB J 8:854\u2013861","journal-title":"FASEB J"},{"key":"1706_CR28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"L Bingle","year":"2002","unstructured":"Bingle L, Brown NJ, Lewis CE (2002) The role of tumour associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254\u2013265","journal-title":"J Pathol"},{"key":"1706_CR29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1747.2000.00029.x","volume":"115","author":"S Wetzler","year":"2000","unstructured":"Wetzler S, Kampfer H, Stallmeyer B, Pfeilschifer J, Frank S (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115:245\u2013253","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1706_CR30","doi-asserted-by":"crossref","first-page":"e9539","DOI":"10.1371\/journal.pone.0009539","volume":"5","author":"S Khanna","year":"2010","unstructured":"Khanna S, Biswas S, Shang Y et al (2010) Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 5(3):e9539","journal-title":"PLoS One"},{"key":"1706_CR31","first-page":"1631","volume":"8","author":"PC Maisonpierre","year":"1993","unstructured":"Maisonpierre PC, Goldfarb M, Yancopoulos GD, Gao G (1993) Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 8:1631\u20131637","journal-title":"Oncogene"},{"key":"1706_CR32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","volume":"87","author":"C Suri","year":"1996","unstructured":"Suri C, Jones PF, Patan S et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171\u20131180","journal-title":"Cell"},{"key":"1706_CR33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1034\/j.1600-0757.2000.024001127.x","volume":"24","author":"L H\u00e4kkinen","year":"2000","unstructured":"H\u00e4kkinen L, Uitto VJ, Larjava H (2000) Cell biology of gingival wound healing. Periodontol 24:127\u2013152","journal-title":"Periodontol"},{"key":"1706_CR34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-013-2613-z","volume":"140","author":"T Kaiser","year":"2013","unstructured":"Kaiser T, Teufel I, Geiger K (2013) Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells. Breast Cancer Res Treat 140:35\u201348","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1706_CR35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tripleo.2008.01.033","volume":"106","author":"S Lehrer","year":"2008","unstructured":"Lehrer S, Montazem A, Ramanathan L et al (2008) Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(3):389\u2013391","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1706_CR36","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.joms.2010.05.043","volume":"68","author":"TS Lazarovici","year":"2010","unstructured":"Lazarovici TS, Mesilaty-Gross S, Vered I et al (2010) Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates. J Oral Maxillofac Surg 68:2241\u20132247","journal-title":"J Oral Maxillofac Surg"},{"key":"1706_CR37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng0494-348","volume":"6","author":"I Satokata","year":"1994","unstructured":"Satokata I, Maas R (1994) Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat Genet 6:348\u2013355","journal-title":"Nat Genet"},{"key":"1706_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0092-8674(05)80083-2","volume":"75","author":"S Vainio","year":"1993","unstructured":"Vainio S, Karavanova I, Jowett A, Thesleff I (1993) Identification of BMP4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 75:45\u201358","journal-title":"Cell"},{"key":"1706_CR39","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1242\/dev.122.10.3035","volume":"122","author":"Y Chen","year":"1996","unstructured":"Chen Y, Bei M, Woo I, Satokata I, Maas R (1996) Msx1 controls inductive signalling in mammalian tooth morphogenesis. Development 122:3035\u20133044","journal-title":"Development"},{"key":"1706_CR40","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1242\/dev.125.21.4325","volume":"125","author":"M Bei","year":"1998","unstructured":"Bei M, Maas R (1998) FGFs and BMP4 induce both Msx1-independent and Msx1-dependent signalling pathways in early tooth development. Development 125:4325\u20134333","journal-title":"Development"},{"key":"1706_CR41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1601-0825.2010.01778.x","volume":"17","author":"F Wehrhan","year":"2011","unstructured":"Wehrhan F, Hyckel P, Amann K et al (2011) Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment. Oral Dis 17:433\u2013442","journal-title":"Oral Dis"},{"key":"1706_CR42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1479-5876-8-96","volume":"8","author":"F Wehrhan","year":"2010","unstructured":"Wehrhan F, Hyckel P, Ries J et al (2010) Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features. J Transl Med 8:96","journal-title":"J Transl Med"},{"key":"1706_CR43","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jcms.2011.10.024","volume":"40","author":"Y Acil","year":"2012","unstructured":"Acil Y, Moller B, Niehoff P et al (2012) The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. J Craniomaxillofac Surg 40:e229\u2013e235","journal-title":"J Craniomaxillofac Surg"},{"key":"1706_CR44","first-page":"4","volume":"11","author":"J Neustadt","year":"2012","unstructured":"Neustadt J, Pieczenik S (2012) A rationale for an approach to preventing and treating bisphosphonate-related osteonecrosis of the jaw with vitamin K2 menaquinone-4. Integr Med 11:4\u201311","journal-title":"Integr Med"},{"key":"1706_CR45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425\u2013510","journal-title":"Nature"},{"key":"1706_CR46","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0022034514564187","volume":"94","author":"Y Nagaoka","year":"2015","unstructured":"Nagaoka Y, Kajiya H, Ozeki S, Ikebe T, Okabe K (2015) Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition. J Dent Res 94:594\u2013601","journal-title":"J Dent Res"},{"key":"1706_CR47","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00784-014-1320-4","volume":"19","author":"N Hagelauer","year":"2015","unstructured":"Hagelauer N, Ziebart T, Pabst AM, Walter C (2015) Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation. Clin Oral Investig 19:1079\u20131091","journal-title":"Clin Oral Investig"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-015-1706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-015-1706-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-015-1706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-015-1706-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T04:16:31Z","timestamp":1654143391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-015-1706-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1007\/s00784-015-1706-y","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]}}}